Sage Therapeutics, Inc.

D. E. Shaw & Co., Inc.

Report date

6/30/2025

Quarter

2025 Q2

Filed

8/14/2025

Shares

1,917,284

Value ($000)

17,486

Weight

0.0%

2019 Q4 - 2025 Q2 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q2	8/14/2025	17,486	0.0%	1,917,284	6/30/2025
2025 Q1	5/15/2025	16,595	0.0%	2,087,443	3/31/2025
2024 Q4	2/14/2025	3,910	0.0%	720,105	12/31/2024
2024 Q3	11/14/2024	4,672	0.0%	647,032	9/30/2024
2024 Q2	8/14/2024	3,522	0.0%	324,271	6/30/2024
2023 Q4	2/14/2024	5,519	0.0%	254,667	12/31/2023
2023 Q3	11/14/2023	4,161	0.0%	202,202	9/30/2023
2023 Q2	8/14/2023	21,219	0.0%	451,272	6/30/2023
2023 Q1	5/15/2023	18,808	0.0%	448,235	3/31/2023
2022 Q4	2/14/2023	22,482	0.0%	589,449	12/31/2022
2022 Q3	11/14/2022	27,471	0.0%	701,484	9/30/2022
2022 Q2	8/15/2022	24,570	0.0%	760,685	6/30/2022
2022 Q1	5/16/2022	30,668	0.0%	926,536	3/31/2022
2021 Q4	2/14/2022	42,296	0.1%	994,269	12/31/2021
2021 Q3	11/15/2021	55,666	0.1%	1,256,291	9/30/2021
2021 Q2	8/16/2021	74,827	0.1%	1,317,143	6/30/2021
2021 Q1	5/17/2021	140,110	0.2%	1,871,875	3/31/2021
2020 Q4	2/16/2021	189,880	0.2%	2,194,887	12/31/2020
2020 Q3	11/16/2020	150,543	0.2%	2,463,066	9/30/2020
2020 Q2	8/14/2020	88,239	0.1%	2,122,156	6/30/2020
2020 Q1	5/15/2020	11,868	0.0%	413,230	3/31/2020
2019 Q4	2/14/2020	5,536	0.0%	76,693	12/31/2019